The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABIOMED INC | COM | 003654100 | 183,344 | 575,233 | SH | SOLE | 0 | 575,233 | 0 | 0 | |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 60,317 | 2,337,877 | SH | SOLE | 0 | 2,337,877 | 0 | 0 | |
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 1,910 | 160,800 | SH | SOLE | 0 | 160,800 | 0 | 0 | |
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 35,976 | 235,276 | SH | SOLE | 0 | 235,276 | 0 | 0 | |
ALIGN TECHNOLOGY INC | COM | 016255101 | 30,003 | 55,405 | SH | SOLE | 0 | 55,405 | 0 | 0 | |
ALIMERA SCIENCES INC | COM NEW | 016259202 | 1,933 | 200,919 | SH | SOLE | 0 | 200,919 | 0 | 0 | |
ALKERMES PLC | SHS | G01767105 | 9,099 | 487,100 | SH | SOLE | 0 | 487,100 | 0 | 0 | |
AMICUS THERAPEUTICS INC | COM | 03152W109 | 96,439 | 9,761,043 | SH | SOLE | 0 | 9,761,043 | 0 | 0 | |
ANAPTYSBIO INC | COM | 032724106 | 9,409 | 436,592 | SH | SOLE | 0 | 436,592 | 0 | 0 | |
ATHENEX INC | COM | 04685N103 | 1,368 | 318,200 | SH | SOLE | 0 | 318,200 | 0 | 0 | |
BIOGEN INC | COM | 09062X103 | 96,010 | 343,200 | SH | SOLE | 0 | 343,200 | 0 | 0 | |
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 166,556 | 2,205,750 | SH | SOLE | 0 | 2,205,750 | 0 | 0 | |
CLOVIS ONCOLOGY INC | COM | 189464100 | 31,481 | 4,484,411 | SH | SOLE | 0 | 4,484,411 | 0 | 0 | |
CYTOKINETICS INC | COM NEW | 23282W605 | 2,877 | 123,686 | SH | SOLE | 0 | 123,686 | 0 | 0 | |
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 8,507 | 332,713 | SH | SOLE | 0 | 332,713 | 0 | 0 | |
EHEALTH INC | COM | 28238P109 | 76,975 | 1,058,370 | SH | SOLE | 0 | 1,058,370 | 0 | 0 | |
EPIZYME INC | COM | 29428V104 | 59,720 | 6,856,513 | SH | SOLE | 0 | 6,856,513 | 0 | 0 | |
GOSSAMER BIO INC | COM | 38341P102 | 16,400 | 1,772,950 | SH | SOLE | 0 | 1,772,950 | 0 | 0 | |
GRITSTONE ONCOLOGY INC | COM | 39868T105 | 21,674 | 2,298,382 | SH | SOLE | 0 | 2,298,382 | 0 | 0 | |
IDERA PHARMACEUTICALS INC | COM PAR | 45168K405 | 100 | 77,044 | SH | SOLE | 0 | 77,044 | 0 | 0 | |
INSMED INC | COM PAR $.01 | 457669307 | 198,383 | 5,824,507 | SH | SOLE | 0 | 5,824,507 | 0 | 0 | |
KALEIDO BIOSCIENCES INC | COM | 483347100 | 6,370 | 786,400 | SH | SOLE | 0 | 786,400 | 0 | 0 | |
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 56,426 | 5,363,652 | SH | SOLE | 0 | 5,363,652 | 0 | 0 | |
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 3,911 | 656,200 | SH | SOLE | 0 | 656,200 | 0 | 0 | |
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 5,118 | 432,300 | SH | SOLE | 0 | 432,300 | 0 | 0 | |
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 485 | 31,330 | SH | SOLE | 0 | 31,330 | 0 | 0 | |
MINERVA NEUROSCIENCES INC | COM | 603380106 | 106 | 36,319 | SH | SOLE | 0 | 36,319 | 0 | 0 | |
PROTHENA CORP PLC | SHS | G72800108 | 43,772 | 1,742,505 | SH | SOLE | 0 | 1,742,505 | 0 | 0 | |
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 13,540 | 1,392,997 | SH | SOLE | 0 | 1,392,997 | 0 | 0 | |
REVANCE THERAPEUTICS INC | COM | 761330109 | 89,492 | 3,201,866 | SH | SOLE | 0 | 3,201,866 | 0 | 0 | |
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 2,231 | 652,395 | SH | SOLE | 0 | 652,395 | 0 | 0 | |
SAGE THERAPEUTICS INC | COM | 78667J108 | 44,947 | 600,500 | SH | SOLE | 0 | 600,500 | 0 | 0 | |
STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 191,204 | 1,813,911 | SH | SOLE | 0 | 1,813,911 | 0 | 0 | |
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 5,908 | 264,200 | SH | SOLE | 0 | 264,200 | 0 | 0 | |
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 603 | 80,600 | SH | SOLE | 0 | 80,600 | 0 | 0 | |
TACTILE SYSTEMS TECHNOLOGY I | COM | 87357P100 | 1,477 | 27,100 | SH | SOLE | 0 | 27,100 | 0 | 0 | |
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 4,147 | 166,069 | SH | SOLE | 0 | 166,069 | 0 | 0 | |
UNITED THERAPEUTICS CORP | COM | 91307C102 | 114,949 | 687,206 | SH | SOLE | 0 | 687,206 | 0 | 0 | |
UROGEN PHARMA LTD | COM | M96088105 | 477 | 24,500 | SH | SOLE | 0 | 24,500 | 0 | 0 | |
VANDA PHARMACEUTICALS INC | COM | 921659108 | 56,953 | 3,791,805 | SH | SOLE | 0 | 3,791,805 | 0 | 0 | |
VIRACTA THERAPEUTICS INC | COM | 92765F108 | 307 | 33,212 | SH | SOLE | 0 | 33,212 | 0 | 0 | |
ZOGENIX INC | COM | 98978L204 | 4,191 | 214,700 | SH | SOLE | 0 | 214,700 | 0 | 0 |